Sartorius Stedim Biotech S.A.
SDMHF
$193.02
-$26.41-12.04%
OTC PK
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 3.01B | 2.97B | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 3.01B | 2.97B | |
| Cost of Revenue | -- | -- | 1.70B | 1.73B | |
| Gross Profit | -- | -- | 1.30B | 1.24B | |
| SG&A Expenses | -- | -- | 702.98M | 700.96M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 18.13M | -61.93M | |
| Total Operating Expenses | -- | -- | 2.58B | 2.52B | |
| Operating Income | -- | -- | 427.74M | 445.49M | |
| Income Before Tax | -- | -- | 237.04M | 256.75M | |
| Income Tax Expenses | -- | -- | 44.26M | 68.32M | |
| Earnings from Continuing Operations | -- | -- | 192.78 | 188.43 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -3.68M | -4.44M | |
| Net Income | -- | -- | 189.10M | 183.99M | |
| EBIT | -- | -- | 427.74M | 445.49M | |
| EBITDA | -- | -- | 680.69M | 699.65M | |
| EPS Basic | -- | -- | 1.95 | 1.92 | |
| Normalized Basic EPS | -- | -- | 0.95 | 0.43 | |
| EPS Diluted | -- | -- | 1.95 | 1.92 | |
| Normalized Diluted EPS | -- | -- | 0.95 | 0.43 | |
| Average Basic Shares Outstanding | -- | -- | 387.70M | 382.81M | |
| Average Diluted Shares Outstanding | -- | -- | 387.70M | 382.81M | |
| Dividend Per Share | -- | -- | 0.74 | 0.74 | |
| Payout Ratio | -- | -- | 38.19% | 39.25% | |